CTMX

CYTOMX THERAPEUTICS INC.

CTMX·23284F105·US·Common Stock·Healthcare - Biotechnology-13D/G

CTMX (CYTOMX THERAPEUTICS INC.) is held by 98 institutional investors as of Q1 2026. Largest holders: FMR LLC ($150.2M), BANK OF AMERICA CORP /DE/ ($48M), VANGUARD CAPITAL MANAGEMENT LLC ($41M). Net institutional sentiment: Bullish.

98
Holders
Avg rating(14 Elite)
$599.6M
Total Value
82% (103)
Fund Consensus
81 buying - 18 selling
CTMXSmart Money Verdict
View all
Held by 98 funds
14 elite
Who's Trading
ActivistPAPerceptive Advisors LLC4.6%May 15, 2026
ActivistVHVenrock Healthcare Capital Partners III, L.P.4.6%May 15, 2026
ActivistKYKynam Capital Management, LP6.9%May 15, 2026
ActivistPGPatrick G. Enright7.0%May 15, 2026
ActivistSFSeven Fleet Master Fund LP0.5%May 15, 2026
ActivistPoint72 Asset Management, L.P.Point72 Asset Management, L.P.5.0%Apr 16, 2026
InsiderMAMcCarthy Sean A.Sell $764KMar 17, 2026
InsiderBMBELVIN MARCIASell $202KMar 17, 2026
InsiderOCOgden ChristopherSell $124KMar 17, 2026
InsiderCYChu Yu-WayeSell $137KMar 17, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
32M(+29.4%)$150.2M0.0%+5.25%
38
Increased
10.2M(+1064.3%)$48M0.0%-19.54%
47
New
8.7M$41M0.0%-21.83%
40
Increased
7.9M(+51.8%)$37M0.0%+17.99%
40
Increased
5.7M(+10.2%)$26.6M0.0%-5.02%
32
Increased
5.4M(+1479.3%)$25.4M0.0%-20.12%
46
Increased
5.2M(+42.5%)$24.6M0.0%+17.13%
38
Increased
5M(+17.1%)$23.4M0.1%+35.54%
40
Increased
4.1M(+257.7%)$19.4M0.0%-8.35%
46
Increased
3.7M(+1163.7%)$17.2M0.0%-19.32%
46
New
3.6M$16.8M0.0%-21.83%
39
Increased
3.1M(+741.6%)$14.7M0.0%-20.03%
45
Increased
3.1M(+128x)$14.4M0.1%-21.63%
45
Increased
2.7M(+73.6%)$12.7M0.0%-8.30%
42
Increased
2.2M(+112.0%)$10.6M0.0%-15.56%
45
Increased
2.1M(+35.5%)$9.7M0.0%-23.89%
36
Decreased
2M(-14.4%)$9.4M0.0%+241.45%
0
Increased
1.9M(+49.7%)$9.1M0.0%-7.52%
38
Increased
1.9M(+90.5%)$8.8M0.0%-10.07%
43
Decreased
1.5M(-40.7%)$6.9M0.0%-5.42%
0

Showing 1-20 of 103

1 / 6

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used